Prediction: These 2 Biotech Stocks Could Double in the Next 5 Years

The biotech industry can be highly volatile. Companies in the sector can sometimes see their shares double in a short period due to hitting important clinical milestones. Over a more extended period, such as five years, it becomes even more common to observe this performance.Two biotechs that have numerous catalysts in place to perform well over the next five years are Viking Therapeutics (NASDAQ: VKTX) and Axsome Therapeutics (NASDAQ: AXSM). To double investors' capital by the end of 2030, these two relatively small drugmakers would each need to record a compound annual growth rate of 14.9% through the next five years. Here's why they could.Image source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool